Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Study of D-Methadone in Patients With Chronic Pain [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating D-Methadone in patients with chronic pain and various cancers has completed enrollment with results po…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer
Completed clinical trial comparing whole-body diffusion-weighted MRI versus choline PET/CT for selecting treatments in recurrent prostate ca…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant hormonal therapy plus docetaxel for node-positive prostate cancer has completed enrollment and posted…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer [Phase 2]
A phase 2 trial evaluating pre-surgical cholecalciferol (vitamin D3) and genistein in patients with early-stage prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy [NA]
A completed clinical trial evaluating the effectiveness of pomegranate pills in men with prostate cancer prior to prostatectomy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer [Phase 2]
This clinical trial update reports Phase 2 results for pemetrexed as second-line therapy in hormone-refractory prostate cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy [Phase 3]
Phase 3 trial investigating tadalafil to prevent erectile dysfunction in men with prostate cancer who received radiation therapy; study comp…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating the safety and tolerability of intraprostatic PRX302 in men with low to intermediate risk prostate cancer has compl…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
An NCI trial update reports cognitive testing of tobacco-use measurement items for administration with cancer patients and survivors; result…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers [NA]
This document reports an update on a clinical trial evaluating rapid prebiopsy MRI combined with biomarkers to improve prostate cancer diagn…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating DR-2031 for hot flashes in prostate cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes [Phase 1]
Phase 1 clinical trial evaluating indocyanine green–based fluorescence imaging to localize prostate cancer and metastatic lymph nodes.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer [NA]
This ClinicalTrials.gov entry reports a completed study evaluating magnetic resonance spectroscopy in localized prostate cancer. The trial d…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer [Phase 2]
This clinical trial update indicates a Phase 2 study evaluating adding androgen suppression to radiation therapy for prostate cancer has com…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
This Phase 2 trial evaluated combination chemotherapy plus filgrastim in patients with stage IV prostate cancer that progressed after hormon…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
This clinical trial update reports on a study examining gene mutations in patients with advanced hormone-refractory prostate cancer. The tri…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer [Phase 2]
This Phase 2 trial update summarizes the results of using hormone therapy followed by internal radiation therapy in patients with locally re…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Phase 3]
Phase 3 trial evaluating octreotide to prevent diarrhea in patients receiving pelvic radiotherapy across multiple pelvic cancers has complet…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer [Phase 3]
This Phase 3 trial evaluates whether adding dalteparin to standard therapy improves outcomes in patients with advanced breast, lung, colorec…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Lycopene in Treating Patients With Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating lycopene in patients with metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
A Phase 2 clinical trial update on Nitrocamptothecin for stage IV prostate cancer that progressed after hormone therapy (study completed).
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate [Phase 2]
Phase 2 clinical trial update on flutamide for prevention of prostate cancer in patients with neoplasia of the prostate; the trial status is…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 clinical trial evaluating green tea extract in patients with metastatic prostate cancer that has not responded to hormone therapy ha…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy [Phase 3]
A Phase 3 randomized trial comparing immediate versus deferred androgen deprivation therapy with goserelin for recurrent prostate cancer aft…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer [Phase 1]
A Phase 1 clinical trial evaluated a MUC1 vaccine in combination with Poly-ICLC in patients with recurrent or advanced prostate cancer. The …